Drug Approval Package
-
Agenerase
(Amprenavir) Capsules
Company: GlaxoSmithKline
Application No.: 21-007/S006 & 21-039/S009
Approval Date: 5/11/2001
-
Approval Letter(s) (PDF)
-
Printed Labeling (PDF)
-
Medical Review(s) (PDF)
-
Chemistry Review(s) (PDF)
-
Pharmacology Review(s) (PDF)
-
Statistical Review(s) (PDF)
-
Microbiology Review(s) (PDF)
-
Correspondence (PDF)
Date created: April 04, 2002
Note: Documents in PDF format require the Adobe Acrobat Reader®.
-